Zw. Lai et al., CYTOKINE GENE-EXPRESSION DURING ONTOGENY IN MURINE THYMUS ON ACTIVATION OF THE ARYL-HYDROCARBON RECEPTOR BY 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN, Molecular pharmacology, 52(1), 1997, pp. 30-37
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) binds and activates the ary
l hydrocarbon receptor (Ah-R), an endogenous transcription factor that
is expressed in the thymus. TCDD exposure leads, among other effects,
to thymus atrophy and immunosuppression. We previously analyzed the i
nterference of TCDD with differentiation processes in fetal thymus org
an cultures and found that in the presence of TCDD, the proliferation
rate of immature (CD4(-)CD8(-) and CD4(-)CD8(+) HSA(+)) thymocytes is
inhibited, whereas the maturation along the CD4/ CD8 path is accelerat
ed. Moreover, the differentiation of thymocytes is skewed by TCDD at l
ess than or equal to 40% (compared with similar to 15% without TCDD) o
f the CD8 single-positive subset of future cytotoxic T cells, and appa
rently more cells audition for and pass positive selection, The fetal
murine thymus expresses functional Ah-R mRNA, as shown by reverse tran
scription-polymerase chain reaction and TCDD-inducible CYP1A1 and CYP1
B1 expression. Because the differentiation of thymocytes is to a consi
derable extent controlled by cytokines and many cytokine genes are pot
ential targets of the Ah-R due to Ah-R-binding elements (xenobiotic re
sponse elements) in their promoters, we analyzed the cytokine expressi
on in fetal thymus organ culture exposed to TCDD. Fetal thymi were cul
tured from gestation day 15 for less than or equal to 8 days, thus cov
ering ex vivo the period after population of the thymus anlage until b
irth. We show with semiquantitative reverse transcription-polymerase c
hain reaction that more interleukin (IL)-1 beta, IL-2, IL-6, tumor gro
wth factor (TGF)-beta 3, and tumor necrosis factor-alpha are produced
in TCDD-exposed thymi, whereas other cytokines (e.g., TGF-beta 1, PA1-
2, or IL-4) are only slightly up- and down-modulated during the cultur
e period or not modulated at all (e.g., IL-1 beta, IL-7, interferon-ga
mma, and TGF-beta 2).